CAPNIA, Inc.

32 articles about CAPNIA, Inc.

• CAPNIA, Inc. Provides Corporate Update And Reports First Quarter 2017 Financial Results

  5/12/2017

• CAPNIA, Inc. Reports Third Quarter 2016 Financial Results

  11/15/2016

• CAPNIA, Inc. Granted Orphan Designation For Nasal CO2 For The Treatment Of Trigeminal Neuralgia

  12/21/2015

• CAPNIA, Inc. Reports Third Quarter 2015 Financial Results

  11/13/2015

• CAPNIA, Inc. Announces Private Placement Of Up To $10 Million Of Convertible Preferred Stock And Warrants

  10/12/2015

• CAPNIA, Inc. To Participate At Upcoming Investor Conferences

  10/1/2015

• CAPNIA, Inc. Announces Publication Of CoSense Clinical Data In The Journal Neonatology

  9/24/2015

• CAPNIA, Inc. Acquires Neonatal Pulmonary Resuscitation Solutions From Neoforce Group

  9/8/2015

• CAPNIA, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference

  9/2/2015

• CAPNIA, Inc. Reports Second Quarter 2015 Financial Results

  8/7/2015

• CAPNIA, Inc. Enters $10 Million Stock Purchase Deal

  7/27/2015

• CAPNIA, Inc. Announces Enrollment Of First Patient In Clinical Trial For Treatment Of Cluster Headache

  7/23/2015

• CAPNIA, Inc. Buys Out Royalty Rights To CoSense

  7/7/2015

• CAPNIA, Inc. Added To Russell Microcap Index

  6/29/2015

• CAPNIA, Inc. Announces Commencement Of Series B Warrant Exchange Offer

  6/26/2015

• CAPNIA, Inc. To Present At 2015 Marcum MicroCap Conference

  5/21/2015

• CAPNIA, Inc. Appoints Edward Ebbers As Chief Commercial Officer

  4/13/2015

• CAPNIA, Inc. Awarded NIH Grant To Develop Sickle Cell Anemia Screening In Developing Countries

  4/6/2015

• CAPNIA, Inc. Announces Receipt Of $3.6 Million From Series B Warrant Exercise And Issuance Of Series C Warrants

  3/5/2015

• CAPNIA, Inc. Announces First U.S. Commercial Sales Of Cosense

  2/17/2015